- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07498738
Making Diabetes Care Fit for Young Adults Living With Type 1 Diabetes: Observations, Reflections and Expert Opinions
The goal of this clinical study is to assess differences in collaborative efforts to make care fit between clinical encounters in usual care and those using the Making Care Fit tool among young adults with type 1 diabetes and their clinicians.
The main question it aims to answer is:
What are the differences in collaborative efforts to make care fit between clinical encounters in usual care and those using the Making Care Fit tool?
Researchers will compare clinical encounters in usual care with encounters supported by the Making Care Fit tool to examine differences in collaborative efforts to align care and daily life.
Participants will:
- Take part in an observed clinical encounter with their clinician
- Participate in a post-encounter video-stimulated interview reflecting on the consultation
- Complete questionnaires about their experiences of the consultation
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Marleen Kunneman, PhD
- Phone Number: 0715263967
- Email: Kunneman@lumc.nl
Study Locations
-
-
South Holland
-
Leiden, South Holland, Netherlands, 2333ZA
- Leiden University Medical Center
-
Contact:
- Anka van Gastel, MSc
- Phone Number: +31625027266
- Email: Ankavangastel@lumc.nl
-
Contact:
- Eelco de Koning, MD, Prof
- Email: e.j.p.de_koning@lumc.nl
-
Rotterdam, South Holland, Netherlands, 3011TA
- Diabeter
-
Contact:
- Anka van Gastel, MSc
- Phone Number: +31625027266
- Email: Ankavangastel@lumc.nl
-
Contact:
- Christine Fransman
- Email: c.fransman@diabeter.nl
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Young adults (age 18-30)
- with ≥1 year since the diagnosis of type 1 diabetes
- receiving ongoing treatment at participating diabetes clinics (Leiden university medical center (LUMC), Diabeter),
- able to speak and read Dutch
- able to provide informed consent for study participation
Exclusion Criteria:
- People who do not fit the participant requirements
- People who cannot give consent themselves (who are incapacitated)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Care as usual
|
Participants receive standard diabetes care at their clinic.
Clinical encounters are observed and assessed to compare collaborative efforts with those in the Making Care Fit Tool arm.
|
|
Experimental: Make Care Fit tool
|
A web-based tool designed to help young adults with type 1 diabetes prepare for care plan design during their clinical encounter by structuring and prioritizing their experiences and efforts in making care fit.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Observable efforts of collaboration to align care and life, with and without using the tool.
Time Frame: 1 month from enrollment to the consultation
|
Qualitative coding of observations
|
1 month from enrollment to the consultation
|
|
Perceived and unobservable efforts to align care and life.
Time Frame: 2 months from enrollment into the study to the video stimulated interview
|
Qualitative coding
|
2 months from enrollment into the study to the video stimulated interview
|
|
Perceived alignment of care plan and life.
Time Frame: 4 months from enrollment to filling out the last questionnaire
|
Young adults & clinicians: Open-ended question: "why does your care plan make sense?"
|
4 months from enrollment to filling out the last questionnaire
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Variety and quality of themes discussed
Time Frame: 1 month from enrollment to consultation
|
Quantitative coding of observations, self-developed
|
1 month from enrollment to consultation
|
|
Collaborative care plan design
Time Frame: 1 month from enrollment to consultation
|
SDMo (reported on 1-10 scale) with higher scores suggesting more collaborative behaviours
|
1 month from enrollment to consultation
|
|
Fidelity of the use of the Making Care Fit tool
Time Frame: 1 month from enrollment to the consultation
|
Quantitative coding of observations, self-developed
|
1 month from enrollment to the consultation
|
|
Unhurried conversations
Time Frame: 1 month from enrollment to consultation
|
Unhurried Collaboration Assessment Tool (UCAT), 37 items to be scored on a 1-5 scale.
|
1 month from enrollment to consultation
|
|
Perceived treatment burden, and acceptability of this burden.
Time Frame: 4 months from enrollment to filling out the last questionnaire
|
Young adults: Treatment Burden Questionnaire (TBQ), 15 items to be scored on a 0-10 scale; 1 item on acceptability of burden.
|
4 months from enrollment to filling out the last questionnaire
|
|
Perceived diabetes distress
Time Frame: 4 months from enrollment to filling out the last questionnaire
|
Young adults: Diabetes distress scale (DDS) screening instrument, 2 items to be scored on a 1-6 scale.
|
4 months from enrollment to filling out the last questionnaire
|
|
Self-reported fidelity of using the Making Care Fit tool outside of the clinical encounter
Time Frame: 1 month from enrollment to concluding the consultation
|
Young adults & clinicians: 3 items about fidelity and and acceptability
|
1 month from enrollment to concluding the consultation
|
|
Perceived clinical empathy
Time Frame: 1 month from enrollment to after the consultation
|
Young adults: Consultation And Relational Empathy (CARE) measure, 10 items to be scored on a 1-5 scale.
|
1 month from enrollment to after the consultation
|
|
Written information by patient in making care fit tool
Time Frame: 1 month from enrollment to having the consultation
|
Qualitative coding
|
1 month from enrollment to having the consultation
|
|
patient involvement
Time Frame: 1 month after enrollment during the clinical consultation
|
OPTION12 (reported on 0-100 scale) with a higher score being more patient involvement
|
1 month after enrollment during the clinical consultation
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Consultation characteristics
Time Frame: 1 month from enrollment to consultation
|
Encounter duration, diabetes clinic, consultation type (in-person or digital)
|
1 month from enrollment to consultation
|
|
Diabetes-specific characteristics
Time Frame: 4 months from enrollment to last questionnaire filled out
|
8 items (self-developed): Treatment regime, year of diagnosis, events of ketoacidosis and hypoglycaemia, HbA1c.
|
4 months from enrollment to last questionnaire filled out
|
|
Consultation characteristic
Time Frame: 4 months from enrollment to last questionnaire
|
1 item (self-developed: Duration of patient/clinician relationship in years
|
4 months from enrollment to last questionnaire
|
|
Work-related characteristics
Time Frame: 1 month from enrollment to consultation
|
2 items (self-developed): Clinicians' years worked, clinical background
|
1 month from enrollment to consultation
|
|
Participant characteristics
Time Frame: 4 months from enrollment to last questionnaire
|
Young adults: 7 items (self-developed): Age, gender, household situation, socioeconomic status, comorbidity, level of education13 Clinicians: 2 items (self-developed): Age, gender. |
4 months from enrollment to last questionnaire
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- nWMOD4- 2025-026
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 1 Diabetes
-
COUR Pharmaceutical Development Company, Inc.RecruitingType 1 Diabetes | Type 1 Diabetes Mellitus | T1DM | T1D | Type 1 Diabetes in Adolescence | Type 1 Diabetes in Children | Type 1 Diabetes Patients | Type 1 Diabetes Mellitis | T1DM - Type 1 Diabetes Mellitus | Type 1 Diabetes (Juvenile Onset)United States
-
Lund UniversityEnrolling by invitationType 1 Diabetes Mellitus | Stage 2 Type 1 Diabetes | Stage 1 Type 1 Diabetes | Stage 3 Type 1 DiabetesSweden
-
Immunocore LtdNot yet recruitingType 1 Diabetes | Diabetes Type 1 | Type 1 Diabetes (T1D)
-
Sultan Qaboos UniversityUniversity of Mosul; University of Child Health Sciences and Children's Hospital...Not yet recruitingType 1 Diabetes Mellitus | T1DM | Type 1 Diabetes Mellitus (T1DM) | T1DM - Type 1 Diabetes Mellitus
-
GentiBio, IncRecruitingType 1 Diabetes Mellitus | Type 1 Diabetes (T1D)United States
-
Stanford UniversityUniversity College Dublin; The Leona M. and Harry B. Helmsley Charitable TrustNot yet recruitingType 1 Diabetes (T1D) | Type 1 Diabetes Mellitus (T1DM) | Exercise Physiology | Type 1 Diabetes MellitisUnited States
-
Dasman Diabetes InstituteRecruitingType 1 Diabetes (T1D) | Type 1 Diabetes Mellitus (T1DM)Kuwait
-
Superior UniversityActive, not recruitingType 2 Diabetes Mellitus 1Pakistan
-
Poznan University of Medical SciencesUnknownDiabetes Mellitus Type 1 | Remission of Type 1 Diabetes | Chronic Complications of DiabetesPoland
-
Insulet CorporationNot yet recruitingType 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes (DM)New Zealand
Clinical Trials on Care as usual
-
Tilburg UniversityElisabeth-TweeSteden Ziekenhuis; Verbeeten InstituteCompletedMyocardial Infarction | Myocardial Ischemia | Autonomic DysfunctionNetherlands
-
Saint Luke's Health SystemBoston Scientific CorporationCompletedCritical Limb IschemiaUnited States
-
Vastra Gotaland RegionEnrolling by invitationCardiovascular Diseases | Lung Diseases | Obesity | Arthritis | Rheumatoid Arthritis | Psoriasis | Psoriatic ArthritisSweden
-
Massachusetts General HospitalNational Institutes of Health (NIH); Samaritans of BostonNot yet recruitingSuicidal Ideation | Suicide, Attempted | Suicide
-
University of RochesterNational Institute of Mental Health (NIMH)CompletedChronic DiseaseUnited States
-
Free University Medical CenterUnknown
-
Technical University of DortmundUniversity of Leipzig; Gaia AGTerminatedBreast CancerGermany
-
Technical University of DortmundUniversity of Leipzig; Gaia AGCompletedBreast CancerGermany
-
The Miriam HospitalCompletedTobacco DependenceUnited States
-
Maastricht University Medical CenterNational Institute for Public Health and the Environment (RIVM); ZonMw: The... and other collaboratorsCompletedChlamydia Trachomatis InfectionNetherlands